These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 7538752

  • 1. Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidates.
    von Specht BU, Domdey H, Schödel F, Blum B, Lücking C, Knapp B, Muth G, Hungerer KD, Bröker M.
    Behring Inst Mitt; 1994 Dec; (95):85-96. PubMed ID: 7538752
    [Abstract] [Full Text] [Related]

  • 2. Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidates.
    von Specht B, Knapp B, Hungerer K, Lücking C, Schmitt A, Domdey H.
    J Biotechnol; 1996 Jan 26; 44(1-3):145-53. PubMed ID: 8717398
    [Abstract] [Full Text] [Related]

  • 3. A hybrid outer membrane protein antigen for vaccination against Pseudomonas aeruginosa.
    Gabelsberger J, Knapp B, Bauersachs S, Enz UI, von Specht BU, Domdey H.
    Behring Inst Mitt; 1997 Feb 26; (98):302-14. PubMed ID: 9382754
    [Abstract] [Full Text] [Related]

  • 4. Recombinant OprF-OprI as a vaccine against Pseudomonas aeruginosa infections.
    Baumann U, Mansouri E, von Specht BU.
    Vaccine; 2004 Feb 17; 22(7):840-7. PubMed ID: 15040936
    [Abstract] [Full Text] [Related]

  • 5. Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa.
    Weimer ET, Ervin SE, Wozniak DJ, Mizel SB.
    Vaccine; 2009 Nov 12; 27(48):6762-9. PubMed ID: 19744586
    [Abstract] [Full Text] [Related]

  • 6. The Pseudomonas aeruginosa outer membrane protein I vaccine: immunogenicity and safe administration in man.
    von Specht BU, Lücking HC, Blum B, Schmitt A, Hungerer KD, Domdey H.
    Behring Inst Mitt; 1997 Feb 12; (98):326-37. PubMed ID: 9382756
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Chimeric influenza viruses incorporating epitopes of outer membrane protein F as a vaccine against pulmonary infection with Pseudomonas aeruginosa.
    Gilleland HE, Gilleland LB, Staczek J, Harty RN, Garcia-Sastre A, Engelhardt OG, Palese P.
    Behring Inst Mitt; 1997 Feb 12; (98):291-301. PubMed ID: 9382753
    [Abstract] [Full Text] [Related]

  • 9. Clinical study to assess the immunogenicity and safety of a recombinant Pseudomonas aeruginosa OprF-OprI vaccine in burn patients.
    Mansouri E, Blome-Eberwein S, Gabelsberger J, Germann G, von Specht BU.
    FEMS Immunol Med Microbiol; 2003 Jul 15; 37(2-3):161-6. PubMed ID: 12832120
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Potential of protein OprF of Pseudomonas in bivalent vaccines.
    Hancock RE, Wong R.
    Behring Inst Mitt; 1997 Feb 15; (98):283-90. PubMed ID: 9382752
    [Abstract] [Full Text] [Related]

  • 12. Salmonella Typhimurium strain expressing OprF-OprI protects mice against fatal infection by Pseudomonas aeruginosa.
    Zhang M, Sun C, Gu J, Yan X, Wang B, Cui Z, Sun X, Tong C, Feng X, Lei L, Han W.
    Microbiol Immunol; 2015 Sep 15; 59(9):533-44. PubMed ID: 26249788
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I/II study.
    Baumann U, Göcke K, Gewecke B, Freihorst J, von Specht BU.
    Respir Res; 2007 Aug 05; 8(1):57. PubMed ID: 17683588
    [Abstract] [Full Text] [Related]

  • 15. Protection of immunosuppressed mice against infection with Pseudomonas aeruginosa by recombinant P. aeruginosa lipoprotein I and lipoprotein I-specific monoclonal antibodies.
    Finke M, Muth G, Reichhelm T, Thoma M, Duchêne M, Hungerer KD, Domdey H, von Specht BU.
    Infect Immun; 1991 Apr 05; 59(4):1251-4. PubMed ID: 1706316
    [Abstract] [Full Text] [Related]

  • 16. Protection against experimental Pseudomonas aeruginosa infection by recombinant P. aeruginosa lipoprotein I expressed in Escherichia coli.
    Finke M, Duchêne M, Eckhardt A, Domdey H, von Specht BU.
    Infect Immun; 1990 Jul 05; 58(7):2241-4. PubMed ID: 2114360
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Production of hybrid protein OprF-OprL of Pseudomonas aeruginosa].
    Kaloshin AA, Mikhaĭlova NA, Leonova EI.
    Zh Mikrobiol Epidemiol Immunobiol; 2012 Jul 05; (3):35-43. PubMed ID: 22830272
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.